Healthcare Industry News: ultrasound
News Release - October 31, 2017
BRH Medical Receives FDA Clearance for its Patented BRH-A2 Combined Ultrasound and Electric Field Stimulation DeviceJERUSALEM, October 31, 2017 -- (Healthcare Sales & Marketing Network) -- BRH Medical, a medical device company developing and marketing innovative products for increasing blood flow and pain reduction, announced today that it has received 510 (k) clearance from the US Food and Drug Administration ("FDA") for its innovative BRH-A2 device.
"FDA clearance for the BRH-A2 represents an important milestone for our company and provides an important key to opening the huge potential of the market in the United States for our product," said Motti Oderberg, CEO, BRH Medical. "We are now exploring the most efficient way to penetrate the market, and are currently focusing on identifying strategic partnerships," Oderberg added.
BRH-A2 technology was developed to reduce pain and facilitate the healing of deep wounds by engaging and stimulating the wounded region from below the wound bed using combined ultrasound and electric field modalities. The ultrasound system is designed to work together with the electric fields to affect the tissues and muscles in the region of, and below the wound. This combination varies in frequency and intensity over the course of the treatment.
The non-invasive BRH-A2 System can be used together with any treatment modality, and its portability permits its use in clinics and hospitals. It features intuitive software for ease of use and is the only one-of-its-kind to include an integrated patient and wound management system.
Ilan Feferberg, BRH Medical Chief Technology Officer and the inventor behind the newly cleared technology explained, "It has always been my desire to develop a product that would truly help cure people. Our grateful patients are proof of the effectiveness of the technology."
Mr. Oderberg concluded, "The market for products that ease the pain of chronic wounds is large and growing. Our vision is to become the gold standard for treatment of chronic wounds of all kinds, including pressure wounds, diabetic leg wounds and wounds caused as a result of ischemia."
About BRH Medical
BRH Medical designs, develops and manufactures advanced medical devices and solutions for chronic wound care. The company's products implement a novel, patented technology that combines therapeutic ultrasound and electrical fields. The company is currently expanding efforts to expand its global presence and will be participating at the Medica Trade Show (Dusseldorf, November 2017).
For more information, visit our web site: http://www.brhmedical.com.
Source: BRH Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.